跳至主要内容
临床试验/CTRI/2025/09/094857
CTRI/2025/09/094857招募中不适用

A Comparative Clinical Approach of Homoeopathic Medicine in LM potency and Centesimal potency in the Modulation of Serum IGE levels in patients with Bronchial Asthma

Dr Saumya Srivastava1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年10月1日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
30
试验地点
1
主要终点
Change in Serum IgE levels in patients with Bronchial Asthma

研究概览

简要总结

Patients diagnosed with Bronchial asthma were selected based on inclusion and exclusion criteria. After obtaining informed consent, baseline data including demographic details, clinical history, serum IgE level, and the score of ACT(Asthma control test) / C-ACT (Childhood Asthma Control Test) questionnaire is recorded.

By following case taking proforma, cases will be taken and the individualized homoeopathic medicine will be selected on the basis of simillimum. Patients divided into the groups will receive Homoeopathic medicine in LM potency and Centesimal potency, to compare the efficacy. Blood Analysis of IgE will be taken before the start of treatment and at the last follow up IgE Level will be tested again.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
6.00 Year(s) 至 75.00 Year(s)(—)
性别
All

入选标准

  • Cases of every age (except children below 6 years of age ) both genders and of different occupations have been included in the study.

排除标准

  • Patients with acute severe asthma or status asthmaticus,patients with cardiac,pulmonary or any other systemic diseases.
  • Pregnant women,Patients who have not given consent for the study, patients with other respiratory ailments, patients with other atopic ailments which increases IgE level like atopic eczema,allergic rhinits.

结局指标

主要结局

Change in Serum IgE levels in patients with Bronchial Asthma

时间窗: Assessed at baseline and after every 5 months.

次要结局

  • To analyze the effect of homoeopathic medicine on the overall quality of life in patients with Bronchial Asthma(Assessed at baseline and after every 5 months.)
  • To observe the disease relation with the potency of LM and Centesimal potency.(Assessed at baseline and after every 5 months)

研究者

发起方
Dr Saumya Srivastava
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Saumya Srivastava

BVDUHMC

研究点 (1)

Loading locations...

相似试验